What does this service help with?
Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.
Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.
Applicability and scope of work are determined on the basis of products, business activities and available information, and costs and delivery are subject to mutually confirmed project arrangements.
Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.
The manufacturer, labeler and team responsible for compliance in the United States market; Specific obligations are judged by the facts of the activities and products of each subject.
Identify information gaps before agreeing on documentation and responsibilities.
Combination of uses, application of crowds, use of the environment, working principles and labels, checking whether they belong to instruments and possible regulatory boundaries.
Queries classification codes, product codes and related listing records, distinguishing between exemptions, routes such as 510(k), De Novo, PMA and issues to be identified.
Provide a basis, preliminary judgement, information gaps and suggested pathways; If formal FDA feedback is required, another 513(g) or communication arrangements apply.
If documents are incomplete, share the product and current stage first. You can provide the remaining details later.
Check products, business roles, existing records and issues to be addressed.
Information gaps, responsibilities of the parties, costs and delivery arrangements are set out on this page.
Collaboration around the assessment, documentation, submission or maintenance of identified issues to be resolved.
Delivery of agreed records or recommendations with clear applicable responsibility for subsequent maintenance.
Registration, listing, submission of or obtaining supporting documents from the database does not amount to FDA approval or full compliance determination. The results of the pre-market declaration are determined by the FDA; Specific exemptions, technical and maintenance requirements should be reconciled with products.
Assessment plans based on use, technical rationale, level of classification disputes and availability of information on the same product.
No uniform number of days for completion of the FDA review for this advisory or information service; If a separate regulatory application is submitted, the official processing time is checked according to the corresponding procedures.
No FDA application fee for internal classification advice; If a separate 513 (g) is submitted, the FY 2027 standard fee US$ 8,596 is determined to be US$ 4,298 for small business fees, and the scope of the application is separately confirmed.
Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.
Testing, translation, software and other third-party work are quoted separately where needed.
Data check: 2026-11-05. The specific application conditions and submission requirements are based on the current official statement of the FDA and the product facts.
Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.